跳至主要内容
临床试验/NCT06214273
NCT06214273尚未招募2 期

Evaluation of Low Level Diode Diode Versus Topical Chamomile in Management of Chemotherapy Induced Oral Mucositis: Three Arm Randomized Clinical Trial

Cairo University0 个研究点目标入组 45 人开始时间: 2024年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
入组人数
45
主要终点
Discomfort and pain

研究概览

简要总结

a three-arm head-to-head randomized clinical trial assessing two of the promising studied interventions, low-level diode laser and topical Chamomile, comparing them to each other's and to conventional therapy in the management of oral mucositis-induced chemotherapy.

详细描述

The latest MASCC/ISOO Mucositis Guidelines recommend relieving pain, reducing inflammation, and preventing secondary infection as the main pillars in the management of chemotherapy-induced oral mucositis. Accordingly, our comparator will be conventional therapy, including topical anti-inflammatory, topical analgesic, and topical antifungal.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Outcomes Assessor)

盲法说明

Double-blinded trial:

The outcome assessor and the statistician will be blinded. Participants can't be blinded because of the difference in intervention methods of application.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Ibuprofen oral gel and miconazole oral gel

Active Comparator

One group will receive conventional oral therapy composed of topical ibuprofen oral gel as an anti-inflammatory and analgesic and topical miconazole as an anti-fungal oral gel.

干预措施: Ibuprofen analgesic and anti-inflammatory oral gel and miconazole anti fungal oral gel (Drug)

low-level diode laser diode laser

Experimental

The second group will receive a diode laser with a wave length range of 800-980 nm and power less than 500 ml.

干预措施: Low level diode laser (Device)

Chamomile

Experimental

The third group will receive chamomile 3% mucoadhesive gel.

干预措施: Chamomile (Drug)

结局指标

主要结局

Discomfort and pain

时间窗: On baseline, first, third, fifth, seventh, tenth and 14th day.

Reported by each patient using the Visual Analog Scale (0-10),10 refers to maximum pain

次要结局

  • Oral mucositis severity(On baseline, first, third, fifth, seventh, tenth and 14th day.)
  • The total healing time of oral ulcers(On baseline, first, third, fifth, seventh, tenth and 14th day.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Clair Sobhy Nagieb Botros

Oral medicine specialist

Cairo University

相似试验